Cat-Nr.	102-PA13
Size	200 µg
Price	290 €
Category	Polyclonal Antibody
Clone Nr.	Rabbit IgG
Isotype	Rabbit IgG
Species Reactivity	Human
Formulation	lyophilized
Buffer	PBS
Reconstitution	Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
Stability and Storage	The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
Preparation	Produced from sera of rabbits immunized with highly pure recombinant humanAGGF1 fragement as the immunizing antigen. Anti-human AGGF1 was purified by affinity chromatography with immobilized Protein A.
Antigen	recombinant human AGGF1 (fragment)
Application	WB, IHC
Synonyms	Angiogenic factor VG5Q, hVG5Q, G patch domain-containing protein 7, Vasculogenesis gene on 5q protein
Description	AGGF1, also known as VG5Q, was identified by its association with Klippel Trenaunay syndrome (KTS), a congenital vascular morphogenesis disorder (1 3). AGGF1 is expressed by vascular endothelial cells in many tissues (1). It appears to be secreted and promotes endothelial cell proliferation following interactions with endothelial cell surfaces (1). AGGF1 also directly interacts with TWEAK (1), a TNF superfamily ligand with angiogenic properties (8). It was shown that AGGF1 is involved in establishing venous identity in zebrafish embryos. Overexpression of AGGF1 led to increased angiogenesis and increased lumen diameter of veins, whereas knockdown of AGGF1 expression resulted in defective vasculogenesis and angiogenesis. Overexpression of AGGF1 increased expression of venous markers (e.g. VEGFR-3/FLT4), but had little effect on arterial markers (e.g. Notch5). Knockdown of AGGF1 expression resulted in a loss of venous identity (loss of expression of VEGFR-3/FLT4, Ephb4 and Dab2), but had no effect on the expression of arterial development. It was further shown that AGGF1 activates AKT, and that decreased AGGF1 expression inhibits AKT activation. Overexpression of constitutively active AKT rescues the loss of venous identity caused by AGGF1 downregulation. These results indicate that AGGF might be an angiogenic factor with an important role in the specification of vein identity and suggests that AGGF1-mediated AKT signaling is responsible for establishing venous cell fate.
Uniprot ID	Q8N302
Protein RefSeq	NP_060516.2.
mRNA RefSeq	NM_018046.4.

RELIATech为在昆虫细胞（杆状病毒）和大肠杆菌中表达重组蛋白提供全面的客户服务。这些服务分为一系列步骤，可以单独执行或组合执行，以便您可以选择实际需要的步骤。这些服务旨在充分满足您的大多数需求，从将基因克隆到杆状病毒转移载体或大肠杆菌表达载体，重组杆状病毒或大肠杆菌菌株的产生到重组蛋白的生产和纯化。如果需要，我们还将尝试建立一种测定纯化蛋白的生物学活性的方法。